An abstract presented at the American Transplant Congress (ATC) in May 2013 by Dr. Victoria Gomez et al. evaluated the budgetary impact and incremental cost-effectiveness of hypothermic machine perfusion compared with static cold storage.1
Kidneys transplanted from expanded criteria donors (ECDs) have a significantly increased incidence of delayed graft function (DGF) compared with kidneys from standard criteria donors,2 which increases post-operative costs due to prolonged hospital stay, the need for dialysis and additional diagnostic procedures.
The short-term cost-effectiveness of ECD transplantation using machine perfusion was reviewed using a probabilistic theoretical decision-tree. The budgetary impact and incremental cost-effectiveness ratio was estimated in terms of the number of DGF and primary non-function (PNF) cases saved by using machine perfusion instead of static cold storage.
The budgetary impact per patient of using machine perfusion was €610, but the incremental cost-effectiveness ratio showed a €16,476 saving for each case of initial graft function achieved. With published data showing that machine perfusion reduces the risk of DGF and PNF compared with static cold storage,3 this study has shown that machine perfusion is a cost effective option despite the initial budgetary impact.
1. Gomez V et al. Economic impact of pulsatile hypothermic perfusion in an expanded criteria donor transplant program. Analysis of the first year since its introduction. Abstract presented at American Transplant Congress, Seattle USA, May 18–22, 2013.
2. Johnson TD et al. Sensitivity of expanded-criteria donor kidneys to cold ischemia time. Clin Transpl 2004;18:28–32.
3. Moers C et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009;360:7–19.
Check out the most recent posts
Novel Oxygenation Technique for Hypothermic Machine Perfusion of Liver Grafts: Validation in Porcine Donation after Cardiac Death (DCD) Liver Model
In a pre-clinical study using a porcine DCD model, Panayotova et al. sought to validate the novel technique of oxygen “pre-charge” for hypothermic machine perfusion (HMP) using the LifePort Liver Transporter. The study evaluated the effects of this preservation method...
David’s Transplant Journey
In this powerful video, we meet David, a liver recipient who shares his journey of needing a liver transplant. David speaks about the emotional and physical toll of waiting for a liver to become available, not knowing when or if he would receive that call. David takes...
Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era
A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes...
Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?
In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...